BioLineRx Ltd.
BioLineRx Ltd. (BLRX) — Form 424B3: Prospectus
About this filing
BioLineRx Ltd. (BLRX) filed Form 424B3 (prospectus) with the SEC on Oct 2, 2026.
Key facts
- Document
- 424B3
More BLRX filings
- 6-K
Filed Nov 18, 2026
- SC 13G
Filed Nov 16, 2026
- 6-K
Filed Nov 16, 2026
- 6-K
Filed Oct 23, 2026
- EFFECT
Filed Oct 4, 2026
- F-1
Filed Sep 25, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.